miR-143 decreases COX-2 mRNA stability and expression in pancreatic cancer cells

Hung Pham1, C Ekaterina Rodriguez, Graham W Donald

  • 1Department of Surgery, UCLA Center of Excellence in Pancreatic Diseases, UCLA David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, CA 90095, United States; Department of Medicine, Veterans Affair Greater Los Angeles Healthcare System, Los Angeles, CA 90073, United States.

Insights

Restoring microRNA-143 (miR-143) in pancreatic cancer cells suppresses tumor growth by inhibiting cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2). This study reveals miR-143 as a key regulator in pancreatic cancer progression.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression by targeting messenger RNAs (mRNAs).
  • Dysregulated miRNA expression is implicated in various cancers, including pancreatic cancer (PaCa).
  • PaCa is characterized by decreased miRNA, elevated cyclooxygenase-2 (COX-2), and increased prostaglandin E2 (PGE2), promoting tumor growth and metastasis.

Purpose of the Study:

  • To investigate the role of miRNA-143 (miR-143) in regulating COX-2 and cell proliferation in pancreatic cancer.
  • To explore the relationship between miR-143, COX-2, PGE2, and MEK/MAPK signaling in PaCa.

Main Methods:

  • Utilized human PaCa cell lines to assess miR-143 levels and its correlation with COX-2, PGE2, and MEK/MAPK activation.
  • Administered MEK inhibitors (U0126, PD98059) to observe effects on miR-143 expression.
  • Performed miR-143 transfection to evaluate its impact on COX-2 mRNA stability, COX-2 expression, cell proliferation, and PGE2 levels.

Main Results:

  • Restoration of miR-143 in PaCa cells significantly inhibited cell proliferation and decreased COX-2 and PGE2 levels.
  • miR-143 transfection reduced COX-2 mRNA stability and suppressed MEK/MAPK activation.
  • Low miR-143 levels correlated with elevated MEK/MAPK activation in specific PaCa cell lines.

Conclusions:

  • Restoring miR-143 expression in pancreatic cancer cells effectively suppresses tumor growth, proliferation, and metastasis.
  • miR-143 acts as a tumor suppressor by downregulating COX-2, PGE2, and MEK/MAPK signaling pathways.
  • These findings highlight miR-143 as a potential therapeutic target for pancreatic cancer treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...